Autologous transplantation of mononuclear bone marrow cells in patients with chronic myocardial infarction

Cor et Vasa

Volumn 49, Issue 2, 2007, Pages 46-54

  Meluzín, Jaroslav ^a   Janoušek, Stanislav ^b   Mayer, Jiří ^b   Groch, Ladislav ^a   Sitar, Jan ^a   Tejc, Miloslav ^a   Kala, Petr ^b   Panovský, Roman ^a   Kamínek, Milan ^c   Klabusay, Martin ^c   Kořístek, Zdeněk ^c   Dušek, Ladislav ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Cell transplantation; Myocardial infarction; Stem cells

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BALLOON DILATATION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY STENT; ENDOPROSTHESIS LOOSENING; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART PERFUSION; HUMAN; HUMAN CELL; IN-STENT RESTENOSIS; INTRACARDIAC THROMBOSIS; MALE; MONONUCLEAR CELL; PATIENT SAFETY; RETREATMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE;

EID: 33847692009     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2007.021     Document Type: Article

References (27)

1. Cleland JGF, Swedberg K, Follath F, et al. The Euro Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Eur Heart J 2003:24:442-63.
2. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002:106:1913-8.
3. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106:3009-17.
4. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Circulation 2003; 108:2212-8.
5. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004;44:1690-9.
6. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
7. Fernández-Avilés F, Román JAS, García-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004:95:742.-8.
8. Chen S, Fang W, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5.
9. Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction. Circulation 2005;112 Suppl 1: I-178-I-183.
10. Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 2004;97:123-7.
11. Janssens S, Dubois Ch, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367: 113-21.
12. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. The IACT study. J Am Coll Cardiol 2005;46:1651-8.
13. Meluzin J, Groch L, Janoušek S, et al. Autologous transplantation of bone marrow cells in patients with acute myocardial infarction. The effect of the number of transplanted cells on the reduction of infarct size. Eur Heart J 2005;26 Suppl:220 [Abstract].
14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-67.
15. Meluzin J, Cigarroa CG, Brickner E, et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995;76:877-80.
16. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery. Circulation 1997; 96:2892-8.
17. Maes AF, Borgers M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. J Am Coll Cardiol 1997;29:62-8.
18. Baer FM, Voth E, Schneider ChA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with (18F) fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 1995:91:1006-15.
19. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells in patients with persistent left ventricular dysfunction after myocardial infarction: a randomized controlled trial (TOPCARE-CHD). Circulation 2005; 112 Suppl II:II-632.
20. Assmus, B, Honold J, Fischer-Rasokat U, et al. Intracoronary cell transplantation in patients with chronic myocardial infarction: a randomized intrapatient comparison of bone marrow-versus blood-derived progenitor cells (TOPCARE-Crossover Trial). Circulation 2005; 112: Suppl 11:11-582.
21. Li RK, Mickle DAG, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957-63.
22. Sakakibara Y, Tambara K, Lu F, et al. Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction. Ann Thorac Surg 2002;74:25-30.
23. Franken P, Maskali F, Lahoutte T, et al. Effect of mesenchymal stem cells on myocardial perfusion and function in a rat model of chronic infarction. Eur Heart J 2005;26 Suppl:686-7 [Abstract].
24. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362:697-703.
25. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110:3300-5.
26. Penicka M, Lang O, Widimsky P, et al. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in human. Eur Heart J 2005;26 Suppl:221 [Abstract].
27. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34/ CXCR4+, CD34/CD117+, c-met+stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110:3213-20.